13-110172627-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001845.6(COL4A1):c.3556+93G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.358 in 1,250,774 control chromosomes in the GnomAD database, including 81,778 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.34 ( 9064 hom., cov: 33)
Exomes 𝑓: 0.36 ( 72714 hom. )
Consequence
COL4A1
NM_001845.6 intron
NM_001845.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.531
Publications
4 publications found
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
- brain small vessel disease 1 with or without ocular anomaliesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
- autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
- microangiopathy and leukoencephalopathy, pontine, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pontine autosomal dominant microangiopathy with leukoencephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinal arterial tortuosityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 13-110172627-C-G is Benign according to our data. Variant chr13-110172627-C-G is described in ClinVar as Benign. ClinVar VariationId is 1261484.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.365 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL4A1 | NM_001845.6 | c.3556+93G>C | intron_variant | Intron 41 of 51 | ENST00000375820.10 | NP_001836.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.344 AC: 52263AN: 151970Hom.: 9047 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
52263
AN:
151970
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.360 AC: 396049AN: 1098686Hom.: 72714 AF XY: 0.361 AC XY: 203308AN XY: 563756 show subpopulations
GnomAD4 exome
AF:
AC:
396049
AN:
1098686
Hom.:
AF XY:
AC XY:
203308
AN XY:
563756
show subpopulations
African (AFR)
AF:
AC:
7805
AN:
26260
American (AMR)
AF:
AC:
17243
AN:
44236
Ashkenazi Jewish (ASJ)
AF:
AC:
7637
AN:
23948
East Asian (EAS)
AF:
AC:
9966
AN:
37954
South Asian (SAS)
AF:
AC:
28806
AN:
79106
European-Finnish (FIN)
AF:
AC:
18988
AN:
53186
Middle Eastern (MID)
AF:
AC:
1201
AN:
4692
European-Non Finnish (NFE)
AF:
AC:
287423
AN:
780980
Other (OTH)
AF:
AC:
16980
AN:
48324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
13622
27245
40867
54490
68112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
7656
15312
22968
30624
38280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.344 AC: 52313AN: 152088Hom.: 9064 Cov.: 33 AF XY: 0.344 AC XY: 25565AN XY: 74346 show subpopulations
GnomAD4 genome
AF:
AC:
52313
AN:
152088
Hom.:
Cov.:
33
AF XY:
AC XY:
25565
AN XY:
74346
show subpopulations
African (AFR)
AF:
AC:
12304
AN:
41484
American (AMR)
AF:
AC:
5495
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
1180
AN:
3470
East Asian (EAS)
AF:
AC:
1508
AN:
5150
South Asian (SAS)
AF:
AC:
1741
AN:
4824
European-Finnish (FIN)
AF:
AC:
3753
AN:
10580
Middle Eastern (MID)
AF:
AC:
87
AN:
292
European-Non Finnish (NFE)
AF:
AC:
25073
AN:
67972
Other (OTH)
AF:
AC:
749
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1778
3556
5335
7113
8891
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
528
1056
1584
2112
2640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1246
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.